The Theranos Crisis: Where Was The Board?

In October 2015, a Wall Street Journal investigation exposed Silicon Valley startup Theranos for making fraudulent claims about its “breakthrough advancements” in blood-testing technologies. Theranos—a privately held company valued at $9 billion—has advertised its proprietary medical technology as being “transformative,” enabling laboratories to run scores of medical tests with merely a finger-prick of blood.